Article Information
History
- November 21, 2022.
Article Versions
- Version 1 (August 9, 2022 - 18:30).
- Version 2 (August 31, 2022 - 10:18).
- Version 3 (October 20, 2022 - 08:49).
- Version 4 (November 8, 2022 - 06:55).
- Version 5 (November 17, 2022 - 14:01).
- You are viewing Version 6, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Sophia T. Tan, BA1,
- Ada T. Kwan, PhD MHS2,3,
- Isabel Rodríguez-Barraquer, MD PhD1,3,
- Benjamin J. Singer, PhD1,
- Hailey J. Park, BA1,
- Joseph A. Lewnard, PhD4,5,6,
- David Sears, MD3,7 and
- Nathan C. Lo, MD PhD1,3,*
- 1Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA, USA
- 2Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, San Francisco, CA, USA
- 3Department of Medicine, University of California, San Francisco, San Francisco, CA, USA
- 4Division of Epidemiology and Biostatistics, School of Public Health, University of California, Berkeley, Berkeley, CA, USA
- 5Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA, USA
- 6Center for Computational Biology, College of Engineering, University of California, Berkeley, Berkeley, CA, USA
- 7Division of Infectious Diseases, University of California, San Francisco, San Francisco, CA, USA
- ↵*Corresponding author: Nathan C. Lo, MD PhD, Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, San Francisco San Francisco, CA, USA 94110, Nathan.Lo{at}ucsf.edu
Posted November 21, 2022.
Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave
